Pharmacogenomic Study in Myeloma Patients Treated With Melphalan-prednisone-thalidomide or Lenalidomide-dexamethasone

NCT00907452 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

143

Enrollment

NETWORK

Sponsor class

Conditions

Myeloma

Interventions

DRUG: melphalan-prednisone-thalidomide
DRUG: lenalidomide-dexamethasone

Sponsor

Intergroupe Francophone du Myelome